AzTrials
AzTrials

Experience, LifeEnquêteXPNCT06529887

What Does the Patient Experience Represent for Patients and Caregivers in Dialysis?

An observational study of Experience, Life and Dialysis, run by Calydial at 4 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary objective of this work is to describe the vision, representations, and beliefs of professionals and patients regarding the role and place of the user during their care journey at the Calydial renal health facility. Methodology: a mixed qualitative and quantitative research. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Experience, Life, Dialysis, Patient Engagement
How many people
160 participants
Where
4 sitesFrance
Study dates
7 Feb 2022to 10 Mar 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Dialysis patients and professionals working at the Calydial renal health facility

Who may be able to join

  • Patient aged 18 years or older
  • On hemodialysis for more than 3 months in one of the participating centers
  • Regardless of the etiology of renal disease

Who cannot join

  • Person refusing to participate in the study
  • Person unable to read or understand French well enough to complete the questionnaires
  • Inability to express consent to participate in the study
  • Cognitive disorders deemed incompatible with study participation by the investigator
  • Psychiatric disorders deemed incompatible with study participation by the investigator
  • Person protected by law
  • Patient under legal protection (safeguard of justice, curatorship, and guardianship)

Trial locations and contacts

4 sites in 1 country.

France4 sites
  • CALYDIAL

    Irigny, 69540

  • CALYDIAL

    Pierre-Bénite, 69310

  • CALYDIAL

    Vénissieux, 69694

  • CALYDIAL

    Vienne, 38200

Other trials in France

About this study

Official title: Evaluate the Vision / Expectations of Patients and Caregivers for Patient-Reported Experience Measures (PREMs). Single-Center Prospective Study (Calydial). Mixed Research (Quantitative and Qualitative)

The primary objective of this work is to describe the vision, representations, and beliefs of professionals and patients regarding the role and place of the user during their care journey at the Calydial renal health facility.

Methodology: a mixed qualitative and quantitative research.

  • Qualitative research: semi-structured interviews with patients and caregivers. The objective is to define the meaning of the patient experience from the perspectives of patients and caregivers.
  • Single-center prospective quantitative study: design of two questionnaires (one for patients and one for caregivers). The objectives of the questionnaires are to:
  • Evaluate the feelings, experiences, and representations/beliefs of the patient experience by caregivers and patients.
  • Assess the understanding of the patient experience by caregivers and patients.
  • Compare the patient experience based on the following parameters: age of patients, gender, treatment duration, treatment location, treatment modality, patient autonomy.
  • Measure the gap between patient and caregiver perspectives to identify/adjust actions.
Read the detailed description

Patient experience encompasses all interactions a healthcare organization has with a patient and their family, potentially influencing their perceptions throughout their healthcare journey. These interactions are shaped both by the policies implemented by the facility and by the personal history and culture of each patient. Patient experience is a subjective concept that can be standardized and objectified. Even if standardized, known as a care pathway, it will still be experienced differently by each patient (depending on whether they are optimistic or pessimistic, live alone or not, and whether they reside in a rural or urban area).

The objective of our work is to evaluate the experience of our care pathway, the factors influencing patient experience, and the caregiver experience. Our facility comprises several units located in the south of Lyon and the north of Isère, providing care for chronic kidney disease at all stages. Our work focused on patients with stage 5 chronic kidney disease treated with hemodialysis (center, medically assisted dialysis unit, and self-dialysis) and home dialysis (hemodialysis and peritoneal dialysis).

The primary objective of this work is to describe the vision, representations, and beliefs of professionals and patients regarding the role and place of the user during their care journey at the Calydial renal health facility.

Methodology: mixed qualitative and quantitative research.

  • Qualitative research: semi-structured interviews with patients and caregivers. The objective is to define the meaning of the patient experience from the perspectives of patients and caregivers.
  • Single-center prospective quantitative study: design of two questionnaires (one for patients and one for caregivers).

The objectives of the questionnaires are to:

  • Evaluate the feelings, experiences, and representations/beliefs of the patient experience by caregivers and patients.
  • Assess the understanding of the patient experience by caregivers and patients.
  • Compare the patient experience based on the following parameters: age of patients, gender, treatment duration, treatment location, treatment modality, patient autonomy.
  • Measure the gap between patient and caregiver perspectives to identify/adjust actions.

Study population The patient and caregiver questionnaires are offered to all patients and caregivers at Calydial.

Inclusions The study population will consist of hemodialysis patients agreeing to respond to the questionnaire during their visit for a dialysis session.

Inclusion criteria:

  • Patient aged 18 years or older
  • On hemodialysis for more than 3 months in one of the participating centers
  • Regardless of the etiology of renal disease

Exclusion criteria:

  • Person refusing to participate in the study
  • Person unable to read or understand French well enough to complete the questionnaires
  • Inability to express consent to participate in the study
  • Cognitive disorders deemed incompatible with study participation by the investigator
  • Psychiatric disorders deemed incompatible with study participation by the investigator
  • Person protected by law
  • Patient under legal protection (safeguard of justice, curatorship, and guardianship)

Study procedure This study is observational and exploratory (non-interventional research), single-center, conducted using a self-administered questionnaire via electronic tablet. The sponsor and investigators commit to conducting this research in accordance with the protocol, Good Clinical Practice guidelines, current legislative and regulatory provisions in France and internationally (particularly the General Data Protection Regulation GDPR).

The study is offered to hemodialysis patients during a dialysis session or consultation. They are informed, and their non-opposition to participation is collected. Their participation consists of:

Responding to an electronic self-assessment questionnaire on the patient experience. A caregiver can assist the patient if necessary. The questionnaire data is pseudonymized.

Providing the following information: age, gender, dialysis modality, dialysis duration, dialysis location, participation in therapeutic education.

Data collected

The quantitative questionnaire for patients will be administered on-site across all dialysis modalities. It includes 4 categories to assess:

  • Patient profile (sociodemographic data)
  • Patient care (dialysis experience, recognizing body reactions, considering opinions, feeling of being heard, etc.)
  • Actions to be implemented (patient participation in ETP workshops, participation in working groups, access to patient associations, considering patient knowledge, etc.)
  • Patient rights (user commission, user projects, patient associations, etc.) The questionnaire will be created using REDCAP software. It will then be tested with 3 patients in a medically assisted dialysis unit and 2 professionals (a clinical research associate and a dietitian). The estimated duration of the questionnaire is 20 to 30 minutes for a patient and about 15 minutes for a professional.

Data analysis An analysis of the sociodemographic and clinical characteristics of the population will be conducted. The proportion of patients included within the total eligible population will be calculated, and the characteristics (sex, age, dialysis duration) of included and eligible non-included patients will be compared to estimate the exhaustiveness and representativeness of the included population.

A descriptive analysis will be carried out to describe the sociodemographic characteristics of the respondents. Subsequently, a comparative analysis will be performed to identify the expectations, needs, and opinions of professionals and patients for quality care. Finally, a multivariate analysis will be conducted to relate sociodemographic variables to the theme of the caregiver-patient relationship.

Analyses will be performed using SAS 9.1 software. A 5% bilateral threshold will be considered for defining statistical significance.

Keywords
patient central care, patient experience, Sharing decision making
Medical subject headings
Patient Participation, Patient Satisfaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06529887
Study groupRoleWhat they receive
PatientsDialysis patients (hemodialysis and peritoneal dialysis)
ProfessionnelsNurses and nephrologists caring for the patient

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Understanding the experiences, knowledge, and patient experience

    Semi-structured interviews with 8 patients (all dialysis modalities) and 8 healthcare professionals to define the objectives of the quantitative survey (patient and caregiver questionnaires).

    Measured: 2 years (2020 and 2021)

  2. Evaluation of the care pathway experiences and factors influencing patient experience from the perspectives of patients and caregivers.

    Quantitative questionnaires for patients (all dialysis modalities) and their caregivers (nephrologists and nurses).

    Measured: 2 months (february and march 2022)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jul 2024
  2. Study start7 Feb 2022
  3. Primary completion10 Mar 2022
  4. Study completion10 Mar 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
160 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06529887
Sponsor's protocol ID
Calydial enquête XP
Acronym
EnquêteXP
Status last verified
Jul 2024
First submitted
1 Jul 2024
Last updated
31 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Experience, Life and Dialysis, run by Calydial at 4 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Understanding the experiences, knowledge, and patient experience (time frame: 2 years (2020 and 2021)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in